Antibacterial and lipopolysaccharide (LPS)-neutralising activity of human cationic antimicrobial peptides against periodontopathogens

International Journal of Antimicrobial Agents

Volumn 35, Issue 2, 2010, Pages 138-145

  Lee, Sung Hoon ^a   Jun, Hye Kyoung ^a   Lee, Hae Ri ^a   Chung, Chong Pyoung ^a   Choi, Bong Kyu ^a  

^a Seoul National University   (South Korea)

Author keywords

Antibacterial activity; Human antimicrobial peptides; LPS neutralisation; Periodontopathogens

Indexed keywords

ANTIMICROBIAL CATIONIC PEPTIDE; BACTERIUM LIPOPOLYSACCHARIDE; BETA DEFENSIN 1; BETA DEFENSIN 2; BETA DEFENSIN 3; BETA DEFENSIN 4; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; DEFENSIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; INTERLEUKIN 8; NEUTROPHIL DEFENSIN 1; NEUTROPHIL DEFENSIN 2; NEUTROPHIL DEFENSIN 3; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BIOLOGICAL ACTIVITY; CARBOHYDRATE ANALYSIS; CARBOHYDRATE TRANSPORT; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; DRUG SCREENING; FIBROBLAST CULTURE; HUMAN; HUMAN CELL; INFECTION PREVENTION; NONHUMAN; PERIODONTITIS; PREVOTELLA INTERMEDIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; TANNERELLA FORSYTHENSIS;

ANTI-BACTERIAL AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; BACTEROIDETES; CELL LINE; CELLS, CULTURED; HUMANS; LIPOPOLYSACCHARIDES; PERIODONTAL DISEASES;

EID: 72449156168     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2009.09.024     Document Type: Article

References (35)

1. Loesche W.J., and Grossman N.S. Periodontal disease as a specific, albeit chronic, infection: diagnosis and treatment. Clin Microbiol Rev 14 (2001) 727-752
2. Taubman M.A., Valverde P., Han X., and Kawai T. Immune response: the key to bone resorption in periodontal disease. J Periodontol 76 (2005) 2033-2041
3. Li X., Kolltveit K.M., Tronstad L., and Olsen I. Systemic diseases caused by oral infection. Clin Microbiol Rev 13 (2000) 547-558
4. Marsh P.D. Are dental diseases examples of ecological catastrophes?. Microbiology 149 (2003) 279-294
5. Kim J., and Amar S. Periodontal disease and systemic conditions: a bidirectional relationship. Odontology 94 (2006) 10-21
6. Udagawa N., Takahashi N., Jimi E., Matsuzaki K., Tsurukai T., Itoh K., et al. Osteoblasts/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor/RANKL but not macrophage colony-stimulating factor: receptor activator of NF-κB ligand. Bone 25 (1999) 517-523
7. Walsh M.C., Kim N., Kadono Y., Rho J., Lee S.Y., Lorenzo J., et al. Osteoimmunology: interplay between the immune system and bone metabolism. Annu Rev Immunol 24 (2006) 33-63
8. Eley B.M., and Cox S.W. Proteolytic and hydrolytic enzymes from putative periodontal pathogens: characterization, molecular genetics, effects on host defenses and tissues and detection in gingival crevice fluid. Periodontol 2000 31 (2003) 105-124
9. Pelt P., Zimmermann B., Ulbrich N., and Bernimoulin J.P. Effects of lipopolysaccharide extracted from Prevotella intermedia on bone formation and on the release of osteolytic mediators by fetal mouse osteoblasts in vitro. Arch Oral Biol 47 (2002) 859-866
10. Socransky S.S., Haffajee A.D., Cugini M.A., Smith C., and Kent Jr. R.L. Microbial complexes in subgingival plaque. J Clin Periodontol 25 (1998) 134-144
11. Tanner A.C., and Izard J. Tannerella forsythia, a periodontal pathogen entering the genomic era. Periodontol 2000 42 (2006) 88-113
12. Sharma A., Inagaki S., Honma K., Sfintescu C., Baker P.J., and Evans R.T. Tannerella forsythia-induced alveolar bone loss in mice involves leucine-rich-repeat BspA protein. J Dent Res 84 (2005) 462-467 [Erratum in: J Dent Res 2005;84:576]
13. Brogden K.A. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?. Nat Rev Microbiol 3 (2005) 238-250
14. Sørensen O.E., Borregaard N., and Cole A.M. Antimicrobial peptides in innate immune responses. Contrib Microbiol 15 (2008) 61-77
15. Rosenfeld Y., Papo N., and Shai Y. Endotoxin (lipopolysaccharide) neutralization by innate immunity host-defense peptides. Peptide properties and plausible modes of action. J Biol Chem 281 (2006) 1636-1643
16. Scott M.G., Gold M.R., and Hancock R.E. Interaction of cationic peptides with lipoteichoic acid and Gram-positive bacteria. Infect Immun 67 (1999) 6445-6453
17. Puklo M., Guentsch A., Hiemstra P.S., Eick S., and Potempa J. Analysis of neutrophil-derived antimicrobial peptides in gingival crevicular fluid suggests importance of cathelicidin LL-37 in the innate immune response against periodontogenic bacteria. Oral Microbiol Immunol 23 (2008) 328-335
18. Lai Y., and Gallo R.L. AMPed up immunity: how antimicrobial peptides have multiple roles in immune defense. Trends Immunol 30 (2009) 131-141
19. Giacometti A., Cirioni O., Ghiselli R., Mocchegiani F., Del Prete M.S., Viticchi C., et al. Potential therapeutic role of cationic peptides in three experimental models of septic shock. Antimicrob Agents Chemother 46 (2002) 2132-2136
20. Lee S.H., Kim K.K., Rhyu I.C., Koh S., Lee D.S., and Choi B.K. Phenol/water extract of Treponema socranskii subsp. socranskii as an antagonist of Toll-like receptor 4 signalling. Microbiology 152 (2006) 535-546
21. Clinical and Laboratory Standards Institute. Methods for antimicrobial susceptibility testing of anaerobic bacteria; approved standard. 7th ed. Document M11-A7. Wayne, PA: CLSI; 2007.
22. Ji S., Hyun J., Park E., Lee B.-L., Kim K.-K., and Choi Y. Susceptibility of various oral bacteria to antimicrobial peptides and to phagocytosis by neutrophils. J Periodontal Res 42 (2007) 410-419 [Erratum in: J Periodontal Res 2008;43:126]
23. Choi B.K., Jung J.H., Suh H.Y., Yoo Y.J., Cho K.S., Chai J.K., et al. Activation of matrix metalloproteinase-2 by a novel oral spirochetal species Treponema lecithinolyticum. J Periodontol 72 (2001) 1594-1600
24. Han S.H., Kim J.H., Martin M., Michalek S.M., and Nahm M.H. Pneumococcal lipoteichoic acid (LTA) is not as potent as staphylococcal LTA in stimulating Toll-like receptor 2. Infect Immun 71 (2003) 5541-5548
25. Franchi L., Eigenbrod T., Muñoz-Planillo R., and Nuñez G. The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis. Nat Immunol 10 (2009) 241-247
26. Peschel A., Jack R.W., Otto M., Collins L.V., Staubitz P., Nicholson G., et al. Staphylococcus aureus resistance to human defensins and evasion of neutrophil killing via the novel virulence factor MprF is based on modification of membrane lipids with l-lysine. J Exp Med 193 (2001) 1067-1076
27. Peschel A., Otto M., Jack R.W., Kalbacher H., Jung G., and Götz F. Inactivation of the dlt operon in Staphylococcus aureus confers sensitivity to defensins, protegrins, and other antimicrobial peptides. J Biol Chem 274 (1999) 8405-8410
28. Hashimoto M., Asai Y., Tamai R., Jinno T., Umatani K., and Ogawa T. Chemical structure and immunobiological activity of lipid A from Prevotella intermedia ATCC 25611 lipopolysaccharide. FEBS Lett 543 (2003) 98-102
29. Kirikae T., Nitta T., Kirikae F., Suda Y., Kusumoto S., Qureshi N., et al. Lipopolysaccharides (LPS) of oral black-pigmented bacteria induce tumor necrosis factor production by LPS-refractory C3H/HeJ macrophages in a way different from that of Salmonella LPS. Infect Immun 67 (1999) 1736-1742
30. Bodet C., Chandad F., and Grenier D. Anti-inflammatory activity of a high-molecular-weight cranberry fraction on macrophages stimulated by lipopolysaccharides from periodontopathogens. J Dent Res 85 (2006) 235-239
31. Visser L.G., Hiemstra P.S., Van Den Barselaar M.T., Ballieux P.A., and Van Furth R. Role of YadA in resistance to killing of Yersinia enterocolitica by antimicrobial polypeptides of human granulocytes. Infect Immun 64 (1996) 1653-1658
32. Campos M.A., Vargas M.A., Regueiro V., Llompart C.M., Albertí S., and Bengoechea J.A. Capsule polysaccharide mediates bacterial resistance to antimicrobial peptides. Infect Immun 72 (2004) 7107-7114
33. Lee S.W., Sabet M., Um H.S., Yang J., Kim H.C., and Zhu W. Identification and characterization of the genes encoding a unique surface (S-) layer of Tannerella forsythia. Gene 371 (2006) 102-111
34. Ouhara K., Komatsuzawa H., Yamada S., Shiba H., Fujiwara T., Ohara M., et al. Susceptibilities of periodontopathogenic and cariogenic bacteria to antibacterial peptides, β-defensins and LL37, produced by human epithelial cells. J Antimicrob Chemother 55 (2005) 888-896
35. Kirkwood K.L., Cirelli J.A., Rogers J.E., and Giannobile W.V. Novel host response therapeutic approaches to treat periodontal diseases. Periodontol 2000 43 (2007) 294-315